A review of several studies looked at how certain molecules, called microRNAs, change in the blood of people with Type 1 Diabetes. These molecules can sometimes act as markers for complications like diabetic nephropathy (kidney damage) and diabetic retinopathy (eye damage).
The analysis focused on two specific markers: miR-29a-3p and miR-204-5p. The results showed that both of these were lower in patients with kidney issues. While these findings identify potential signals for future research, the study noted a lot of differences in how the individual studies were conducted.
It is important to know that no single universal marker was found for all types of complications. These results are currently used to identify candidates for future testing rather than as immediate tools for diagnosis. Patients should talk to their doctors about how these findings might impact their specific care plans.
